Alejandro G. Szmulewicz, MD, MPH

Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts; Corresponding author: Alejandro G. Szmulewicz, MD, MPH, Department of Epidemiology, Harvard T.H. Chan School of Public Health, 677 Huntington Ave, Boston, MA, 02115 ([email protected]).

JCP
Original Research

April 13, 2021

Antipsychotics may have immunomodulatory effects that could increase the risk of disseminated infections. This study sought to estimate the effect of antipsychotics on incident bloodstream infections in adults with...
Augusto Ferraris, Belén Blasco, Nicolás Tentoni, et al
JCP
Original Research

August 27, 2019

Use of antipsychotics is associated with incident venous thromboembolism (VTE).  Read this article to learn if these agents also increase the risk of recurrent VTE in individuals with previous...
Augusto Ferraris, Alejandro G. Szmulewicz, M. Lourdes Posadas-Martínez, et al
JCP
Article

April 11, 2017

Does your patient who is at high risk of cardiovascular disease need antipsychotic treatment? Read this article for insight on which antipsychotic medications have the lowest incidence of major...
Alejandro G. Szmulewicz, Federico Angriman, Felipe E. Pedroso, et al

Celebrating
85 Years

Read the Journal of Clinical Psychiatry

Subscribe to read
more articles

Subscribe